Fusion Pharmaceuticals Announces First Quarter 2023 Financial Results and Clinical Program Updates ...Middle East

PR Newswire - News
Fusion Pharmaceuticals Announces First Quarter 2023 Financial Results and Clinical Program Updates
FPI-2265 (Ac-PSMA I&T) program enrolling patients and on track for Q1 2024 update Preliminary Phase 1 data for FPI-1434 expected to be reported at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting Clinical progress across TAT pipeline continues; first patient...

Hence then, the article about fusion pharmaceuticals announces first quarter 2023 financial results and clinical program updates was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Fusion Pharmaceuticals Announces First Quarter 2023 Financial Results and Clinical Program Updates )

Apple Storegoogle play

Last updated :

Also on site :